| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2014 | US20140024674 Trpm5 inhibitors support body weight reduction without reducing food intake |
| 01/23/2014 | US20140024672 Azaindole derivatives as cftr modulators |
| 01/23/2014 | US20140024671 Compositions and methods for inhibiting cytochrome p450 |
| 01/23/2014 | US20140024670 Veterinary anti-prolactin composition for ruminants |
| 01/23/2014 | US20140024669 Tamper resistant dosage forms |
| 01/23/2014 | US20140024663 Atb(0,+) amino acid transporter as a drug target for treatment of estrogen receptor-positive breast cancer |
| 01/23/2014 | US20140024658 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 01/23/2014 | US20140024655 Janus kinase 2 (jak2) inhibitor for the treatment of lupus |
| 01/23/2014 | US20140024653 Compositions and methods for treating cancer using pi3k inhibitor and mek inhibitor |
| 01/23/2014 | US20140024652 Substituted triazolophthalazine derivatives |
| 01/23/2014 | US20140024648 New pyridazinone and pyridone compounds |
| 01/23/2014 | US20140024642 Ophthalmic formulation and method for ameliorating presbyopia |
| 01/23/2014 | US20140024641 Treatment of organophosphate exposure with triptans |
| 01/23/2014 | US20140024639 Compounds, Compositions, and Methods for Cancer Therapy |
| 01/23/2014 | US20140024638 Treatment of cognitive dysfunction in schizophrenia |
| 01/23/2014 | US20140024633 Orally administrable gallium compositions and methods of use |
| 01/23/2014 | US20140024632 Methods for treatment of autism spectrum disorder |
| 01/23/2014 | US20140024631 Steroids as Agonists for FXR |
| 01/23/2014 | US20140024630 Method for the non-surgical treatment of lipodystrophy in a retrovirus-infected individual |
| 01/23/2014 | US20140024629 Compositions and methods for the treatment of skin diseases |
| 01/23/2014 | US20140024628 Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof |
| 01/23/2014 | US20140024627 Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases |
| 01/23/2014 | US20140024626 Use of canthaxanthin and/or 25-oh d3 for improved hatchability in poultry |
| 01/23/2014 | US20140024625 Compositions and methods for using same for improving the quality of the meibum composition of meibomiam glands |
| 01/23/2014 | US20140024624 Method of Ameliorating Clotting Pathologies and Related Materials and Methods |
| 01/23/2014 | US20140024623 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment |
| 01/23/2014 | US20140024622 Compositions comprising tramadol and celecoxib in the treatment of pain |
| 01/23/2014 | US20140024621 Aminopyridine compounds and their uses |
| 01/23/2014 | US20140024618 Indole compounds as an inhibitor of cellular necrosis |
| 01/23/2014 | US20140024615 Compositions and methods for preventing infectious diseases in females |
| 01/23/2014 | US20140024614 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides |
| 01/23/2014 | US20140024613 Methods for Treating HCV |
| 01/23/2014 | US20140024610 Nanoparticles loaded with chemotherapeutic antitumoral drug |
| 01/23/2014 | US20140024609 Treatment of Bacterial Infections |
| 01/23/2014 | US20140024608 Inhibitors of histone deacetylase and prodrugs thereof |
| 01/23/2014 | US20140024607 Ngna compositions and methods of use |
| 01/23/2014 | US20140024602 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 01/23/2014 | US20140024598 Methods and compositions for preserving retinal ganglion cells |
| 01/23/2014 | US20140024596 Disease inhibiting agent |
| 01/23/2014 | US20140024594 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 01/23/2014 | US20140024592 Modified Relaxin Polypeptides |
| 01/23/2014 | US20140024587 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 01/23/2014 | US20140024585 Composition for the therapy of diabetes mellitus and adiposity |
| 01/23/2014 | US20140024584 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| 01/23/2014 | US20140024583 Organic compounds |
| 01/23/2014 | US20140024579 Methods for treating hcv |
| 01/23/2014 | US20140024576 Heptose derivatives for use in the treatment of bacterial infections |
| 01/23/2014 | US20140023729 Nutritional supplement for disinhibiting therapy of psychiatric patients |
| 01/23/2014 | US20140023726 Polymorphisms predictive of platinum-coordinating complex induced ototoxicity |
| 01/23/2014 | US20140023717 Methods and compositions for treating proliferative diseases |
| 01/23/2014 | US20140023710 Milnacipran formulations |
| 01/23/2014 | US20140023707 Co-Processed Carbohydrate System as a Quick-Dissolve Matrix for Solid Dosage Forms |
| 01/23/2014 | US20140023706 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof |
| 01/23/2014 | US20140023705 Dosage forms for oral administration and methods of treatment using the same |
| 01/23/2014 | US20140023704 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| 01/23/2014 | US20140023703 Nanocapsules with a polymer shell |
| 01/23/2014 | US20140023701 Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress |
| 01/23/2014 | US20140023700 Cyclic peptide and conjugate thereof for binding to keratinocytes |
| 01/23/2014 | US20140023699 Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration |
| 01/23/2014 | US20140023698 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 01/23/2014 | US20140023695 Patch preparation |
| 01/23/2014 | US20140023692 Drug delivery device |
| 01/23/2014 | US20140023675 Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus |
| 01/23/2014 | US20140023668 C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| 01/23/2014 | US20140023667 Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| 01/23/2014 | US20140023665 Novel maytansinoid derivatives with sulfoxide linker |
| 01/23/2014 | US20140023663 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3-Dioxygenase |
| 01/23/2014 | US20140023661 Combination therapy |
| 01/23/2014 | US20140023658 Regulating il-4 and il-3 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
| 01/23/2014 | US20140023654 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 01/23/2014 | US20140023653 Boldine derivatives for promoting bone growth |
| 01/23/2014 | US20140023647 Method for treating solid tumors |
| 01/23/2014 | US20140023643 N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/23/2014 | US20140023636 Aminocarboxylic acid derivative and medicinal use thereof |
| 01/23/2014 | US20140023634 Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated epa and dha |
| 01/23/2014 | US20140023633 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 01/23/2014 | US20140023627 Topical co-enzyme q10 formulations and methods of use |
| 01/23/2014 | US20140023625 Biological effects of compositions of rosmarinic acid |
| 01/23/2014 | US20140023618 Systems and methods for treatment of androgenetic skin conditions by microbial organisms |
| 01/23/2014 | US20140023614 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 01/23/2014 | US20140023611 Compounds and methods for inhibiting phosphate transport |
| 01/23/2014 | US20140023599 Water-soluble pharmaceutical compositions of hops resins |
| 01/23/2014 | US20140023597 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme |
| 01/23/2014 | US20140023590 Novel block copolymer and micelle compositions and methods of use thereof |
| 01/23/2014 | DE102012105613A1 Refining method useful e.g. for separating biologically active substances from several prenylated polyphenols mixture, comprises e.g. applying solution of mixture on solid phase, eluting biologically active substance and collecting eluates |
| 01/23/2014 | DE102012014465A1 Emulsion, useful in a mixture with known skin care or wound-healing components for improving oxygen supply of human tissue, preferably skin or wound tissue, comprises perfluorocarbon compound and water, and polyelectrolyte |
| 01/23/2014 | DE102012014464A1 Formulation useful for topical application of perfluorocarbon combounds, comprises perfluorocarbon combound, which is bound to solid surface |
| 01/23/2014 | CA2877232A1 Prophylactic/therapeutic agent for influenza virus infection |
| 01/23/2014 | CA2876303A1 Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder |
| 01/23/2014 | CA2875784A1 Pharmaceutical compositions containing oligomeric lactic acid |
| 01/23/2014 | CA2875351A1 Injectable antibiotic formulations and their methods of use |
| 01/22/2014 | EP2687533A2 Acrylamide derivatives as FAB I inhibitors |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | EP2687531A1 Tetrahydrocarboline derivative |
| 01/22/2014 | EP2687529A1 Condensed heterocyclic compound |
| 01/22/2014 | EP2687528A1 Fused triazole derivatives as gamma secretase modulators |
| 01/22/2014 | EP2687526A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent HCV inhibitor |
| 01/22/2014 | EP2687525A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/22/2014 | EP2687524A1 Azole derivative |